skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Significance of /sup 99m/Tc-sulfur colloid splenic image in malignant melanoma

Journal Article · · J. Surg. Oncol.; (United States)

To evaluate the clinical significance of /sup 99m/Tc-sulfur-colloid (TcSC) spleen scan findings in patients with malignant melanoma, a retrospective study was undertaken. Eighty-one patients with histologically proven malignant melanoma who received treatment in Roswell Park during a five-year period were included in this study. The scans were analyzed for spleen size, differential uptake of the tracer in liver and spleen, and for the presence of metastases in these two organs. These data were compared with stage of disease, survival, and autopsy findings. Significant correlation was found between the splenic size as measured on the scintiscan and at autopsy examination. The spleen size was found to be normal in 92% of the patients in early melanoma. The median survival of patients who had a normal-sized spleen by scan criteria was found to be longer than those who had splenomegaly. No significant difference in survival was noted between the patients with and without augmented splenic uptake of TcSC. Only a small number (17.7%) of patients with augmented splenic uptake had splenic metastases; hence, the possible role of immunological factors was considered.

Research Organization:
Roswell Park Memorial Inst., Buffalo, NY
OSTI ID:
5437030
Journal Information:
J. Surg. Oncol.; (United States), Vol. 13:1
Country of Publication:
United States
Language:
English

Similar Records

Prognosis in Stage 1 malignant melanoma: seven-year follow-up study of splenic radiocolloid uptake as predictor of death
Journal Article · Thu Nov 01 00:00:00 EST 1984 · J. Nucl. Med.; (United States) · OSTI ID:5437030

Significance of augmented radiocolloid uptake by the spleen in patients with malignant melanoma. [/sup 99m/Tc]
Journal Article · Sat Dec 01 00:00:00 EST 1979 · J. Nucl. Med.; (United States) · OSTI ID:5437030

Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen
Journal Article · Thu Jan 01 00:00:00 EST 1987 · NCI Monogr.; (United States) · OSTI ID:5437030